Could a single weekly shot replace daily insulin injections for millions?

This study is testing if a new weekly insulin injection (GZR4) works as well and is as safe as the standard daily insulin (glargine) for people with type 2 diabetes who haven't started insulin yet. It will involve about 580 participants and will compare how well each treatment controls blood sugar levels, along with side effects like low blood sugar and weight changes. The goal is to see if a less frequent injection schedule can effectively manage the disease.